Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Banna

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The European Respiratory Journal|April 6, 2018
Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 diseaseAlfredo Addeo, Giuseppe Banna
ESMO Open|July 6, 2019
New emerging targets in cancer immunotherapy: the role of TIM3Alex Friedlaender, Alfredo Addeo, Giuseppe Banna
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2020
Filtering Data About Treatment-Induced Renal Injury: From Biology to PracticeAlfredo Addeo, Luigi Giuseppe Banna, Alex Friedlaender
Current Treatment Options in Oncology|September 5, 2019
Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLCAlex Friedlaender, Giuseppe Banna, Sandip Patel, et al.
ESMO Open|May 16, 2020
Reply to AuthorsGiuseppe Banna, Alessandra Curioni-Fontecedro, Alex Friedlaender, et al.
ESMO Open|April 5, 2020
How we treat patients with lung cancer during the SARS-CoV-2 pandemic: <i>primum non nocere</i>Giuseppe Banna, Alessandra Curioni-Fontecedro, Alex Friedlaender, et al.
Therapeutic Advances in Drug Safety|April 15, 2021
Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative reviewLaure Thouvenin, Timothée Olivier, Giuseppe Banna, et al.
Critical Reviews in Oncology/Hematology|June 3, 2020
A BRAF new worldDaniele Frisone, Alex Friedlaender, Umberto Malapelle, et al.
Frontiers in Oncology|April 4, 2019
Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?Alex Friedlaender, Giuseppe Banna, Umberto Malapelle, et al.
The Annals of Thoracic Surgery|June 30, 2009
Is a 1-cm margin from major vessels adequate for radiofrequency ablation of pulmonary neoplasms?Antonio Basile, Giuseppe Banna, Salvatore Saita, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The European Respiratory Journal|April 6, 2018
Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 diseaseAlfredo Addeo, Giuseppe Banna
ESMO Open|July 6, 2019
New emerging targets in cancer immunotherapy: the role of TIM3Alex Friedlaender, Alfredo Addeo, Giuseppe Banna
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2020
Filtering Data About Treatment-Induced Renal Injury: From Biology to PracticeAlfredo Addeo, Luigi Giuseppe Banna, Alex Friedlaender
Current Treatment Options in Oncology|September 5, 2019
Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLCAlex Friedlaender, Giuseppe Banna, Sandip Patel, et al.
ESMO Open|May 16, 2020
Reply to AuthorsGiuseppe Banna, Alessandra Curioni-Fontecedro, Alex Friedlaender, et al.
ESMO Open|April 5, 2020
How we treat patients with lung cancer during the SARS-CoV-2 pandemic: <i>primum non nocere</i>Giuseppe Banna, Alessandra Curioni-Fontecedro, Alex Friedlaender, et al.
Therapeutic Advances in Drug Safety|April 15, 2021
Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative reviewLaure Thouvenin, Timothée Olivier, Giuseppe Banna, et al.
Critical Reviews in Oncology/Hematology|June 3, 2020
A BRAF new worldDaniele Frisone, Alex Friedlaender, Umberto Malapelle, et al.
Frontiers in Oncology|April 4, 2019
Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?Alex Friedlaender, Giuseppe Banna, Umberto Malapelle, et al.
The Annals of Thoracic Surgery|June 30, 2009
Is a 1-cm margin from major vessels adequate for radiofrequency ablation of pulmonary neoplasms?Antonio Basile, Giuseppe Banna, Salvatore Saita, et al.
Pageof 3